Bank of America’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $195M | Sell |
|
|||||
|
2025
Q2 | $195M | Buy |
|
|||||
|
2025
Q1 | $98.3M | Buy |
|
|||||
|
2024
Q4 | $67M | Sell |
|
|||||
|
2024
Q3 | $92.4M | Buy |
|
|||||
|
2024
Q2 | $86.4M | Buy |
|
|||||
|
2024
Q1 | $93.2M | Buy |
|
|||||
|
2023
Q4 | $73M | Sell |
|
|||||
|
2023
Q3 | $74.9M | Sell |
|
|||||
|
2023
Q2 | $74.5M | Sell |
|
|||||
|
2023
Q1 | $74.5M | Sell |
|
|||||
|
2022
Q4 | $82.5M | Sell |
|
|||||
|
2022
Q3 | $74.9M | Sell |
|
|||||
|
2022
Q2 | $139M | Buy |
|
|||||
|
2022
Q1 | $133M | Sell |
|
|||||
|
2021
Q4 | $137M | Sell |
|
|||||
|
2021
Q3 | $138M | Buy |
|
|||||
|
2021
Q2 | $128M | Buy |
|
|||||
|
2021
Q1 | $112M | Sell |
|
|||||
|
2020
Q4 | $125M | Sell |
|
|||||
|
2020
Q3 | $213M | Sell |
|
|||||
|
2020
Q2 | $256M | Sell |
|
|||||
|
2020
Q1 | $259M | Sell |
|
|||||
|
2019
Q4 | $350M | Buy |
|
|||||
|
2019
Q3 | $311M | Sell |
|
|||||
|
2019
Q2 | $312M | Sell |
|
|||||
|
2019
Q1 | $338M | Buy |
|
|||||
|
2018
Q4 | $292M | Sell |
|
|||||
|
2018
Q3 | $332M | Buy |
|
|||||
|
2018
Q2 | $310M | Sell |
|
|||||
|
2018
Q1 | $302M | Buy |
|
|||||
|
2017
Q4 | $240M | Sell |
|
|||||
|
2017
Q3 | $411M | Buy |
|
|||||
|
2017
Q2 | $329M | Buy |
|
|||||
|
2017
Q1 | $289M | Buy |
|
|||||
|
2016
Q4 | $228M | Sell |
|
|||||
|
2016
Q3 | $288M | Buy |
|
|||||
|
2016
Q2 | $266M | Buy |
|
|||||
|
2016
Q1 | $207M | Buy |
|
|||||
|
2015
Q4 | $177M | Sell |
|
|||||
|
2015
Q3 | $171M | Buy |
|
|||||
|
2015
Q2 | $101M | Sell |
|
|||||
|
2015
Q1 | $130M | Sell |
|
|||||
|
2014
Q4 | $178M | Sell |
|
|||||
|
2014
Q3 | $502M | Buy |
|
|||||
|
2014
Q2 | $576M | Buy |
|
|||||
|
2014
Q1 | $492M | Buy |
|
|||||
|
2013
Q4 | $451M | Buy |
|
|||||
|
2013
Q3 | $166M | Sell |
|
|||||
|
2013
Q2 | $170M | Buy |
|